21.2 C
Rome
Friday, October 9, 2026
HomeTechnologyRussian Health Authorities Deny Second Illness at Plague Research Facility

Russian Health Authorities Deny Second Illness at Plague Research Facility

Date:

Related stories

“20 Years Later: Former Soldier Recounts Taliban Ambush”

Former corporal Bruce Moncur vividly remembers the moment Canadian...

“Canada Dominates New Zealand, Advances to FIBA Pre-Qualifying Final”

Canada showcased a dominant performance against New Zealand, securing...

Mexican Court Issues Arrest Warrants in Condo Scam

A Mexican court has issued arrest warrants for a...

“Miyu Yamashita Dominates CPKC Women’s Open in Edmonton”

Miyu Yamashita extended her commanding lead, while Canadian teenager...

Quebec Demands Answers After Child’s Tragic Death

Quebec officials are expressing strong disapproval following the passing...

Russian health authorities have refuted claims of a second individual falling ill following the demise of a worker at a plague research facility in Siberia. The regulator dismissed what it labeled as false information circulating on social media regarding another case of illness. They confirmed that all contacts of the deceased woman had been checked, revealing no health issues related to infectious diseases. Nearly 5,000 laboratory tests conducted showed no presence of dangerous pathogens.

The worker, Daria Shipilova, aged 28, passed away from pneumonia of an undetermined origin at the Irkutsk Anti-Plague Research Institute in Siberia. Russian officials swiftly implemented precautionary anti-epidemic measures in response to the incident. Shipilova, an employee at the institute, was vaccinated and reportedly immune to the infections she worked with.

The World Health Organization initially assessed the public risk level as low in the Russian case but cited insufficient information from Russian authorities for a comprehensive risk evaluation. The WHO extended assistance to Russia and sought verification of reports about a second employee with pneumonia of unknown cause. Health organizations in Canada and the U.S. are closely monitoring the situation, with both countries reporting minimal risk to their populations. Health authorities have heightened surveillance and screening measures for travelers from the affected region.

Latest stories